Based on the circular-by-design concept, the goal is to optimize resource recovery at an early stage in the design phase and minimize the environmental footprint of the pharma production. Innovative adaption of known technologies for new applications will be done by appropriate providers of key technology. The technological solutions are generic by nature which, when validated, will have significant potential for commercialization of resources recovery within a range of industrial sectors.